These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 4137369

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Therapeutic consequences of immunologic reactions in manifest tetanus].
    Hiotakis K, Feischl P.
    Munch Med Wochenschr; 1971 Nov 19; 113(47):1591-5. PubMed ID: 4109151
    [No Abstract] [Full Text] [Related]

  • 5. [On the problem of the use of homologous tetanus antitoxins in the treatment of severe tetanus: clinical and immunologic studies following treatment with human tetanus-hyperimmunoglobulin].
    Auerswald W, Brücke P, Kucher R, Marsoner F, Müller H, Seidl H, Steinbereithner K, Wagner E.
    Wien Med Wochenschr; 1966 Mar 12; 116(11):229-35. PubMed ID: 4168478
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Evaluation of antitoxin and antibacterial activity of human preparations of normal immunoglobulin. I. Level of tetanus antitoxin in preparations of IMIG and IVIG].
    Zakrzewska A, Rymkiewicz D.
    Przegl Epidemiol; 1995 Mar 12; 49(4):381-4. PubMed ID: 8868196
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of tetanus.
    Ildirin I, Vandiviere HM.
    Lancet; 1969 Jun 14; 1(7607):1211. PubMed ID: 4181858
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Use of human immunoglobulin in tetanus].
    Burkhardt G, Starke G, Seifart W.
    Zentralbl Chir; 1970 Feb 07; 95(6):180-4. PubMed ID: 4104896
    [No Abstract] [Full Text] [Related]

  • 14. [Immunogenicity of tetanus toxoid used in conjunction with high doses of tetanus antitoxin].
    Galazka A, Januszkiewicz J, Sporzyńska Z, Adamczyk J.
    Przegl Epidemiol; 1974 Feb 07; 28(3):345-53. PubMed ID: 4409780
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Antitetanus antibodies. Assay before anatoxinotherapy in 64 tetanus patients].
    Goulon M, Girard O, Grosbuis S, Desormeau JP, Capponi MF.
    Nouv Presse Med; 1972 Dec 16; 1(45):3049-50. PubMed ID: 4675227
    [No Abstract] [Full Text] [Related]

  • 19. [Treatment of manifest tetanus].
    Wiemers K, Eyrich K.
    Dtsch Med Wochenschr; 1967 Jun 16; 92(24):1113-7. PubMed ID: 4165123
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.